Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ro 205-2349 in type 2 diabetes
NCT00057317Phase 2Completed
- Sponsor
- Roche
- Start
- Dec 2001
- Primary completion
- Dec 2003
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 2 trial of edaglitazone in type 2 diabetes mellitus (T2DM), sponsored by Roche. Started Dec 2001; status: completed.
02
Drugs
edaglitazone
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00057317.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00057317.